Review: taking Meloxicam and Requip together


Summary

Drug interactions are reported among people who take Meloxicam and Requip together. This review analyzes the effectiveness and drug interactions between Meloxicam and Requip. It is created by eHealthMe based on reports of 204 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Meloxicam and Requip >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meloxicam

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 10,177 users)

Requip

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. (latest outcomes from Requip 11,812 users)

On Jul, 26, 2016

204 people who take Meloxicam, Requip are studied.


Number of reports submitted per year:

Meloxicam and Requip drug interactions.

Drug effectiveness over time:

Meloxicam:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 16.0% - (1 of 6 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 33.0% - (2 of 6 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)
Requip:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 5 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 5 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Meloxicam:
  • female: 26.0% - (4 of 15 people)
  • male: 0.0% - (0 of 1 people)
Requip:
  • female: 14.0% - (2 of 14 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Meloxicam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 40.0% - (2 of 5 people)
Requip:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 8 people)
  • 60+: 40.0% - (2 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • abnormal behaviour
  • arthralgia
  • back pain
  • blood creatinine increased
  • confusional state
  • conjunctivitis
  • gastroenteritis
  • hallucination
  • peripheral ischaemia
  • pollakiuria
1 - 6 months:
  • depression
  • emotional distress
  • hypersexuality
  • obsessive-compulsive personality disorder
  • pathological gambling
  • suicidal ideation
  • cold sweat
  • dyspnoea
  • hyperhidrosis
  • nausea
6 - 12 months:
  • depression
  • pain
  • anxiety
  • bluish lips and fingernails
  • cataract
  • compulsions
  • compulsive hoarding
  • constipation
  • crying
  • decreased interest
1 - 2 years:
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • liver function test abnormal
  • nausea
  • weight gain - unintentional
  • blood alkaline phosphatase decreased
  • dysuria
2 - 5 years:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • aphasia
  • breathlessness
  • nausea
  • numbness and tingling
  • constipation
  • muscle spasms
  • sleep disorder due to general medical condition, insomnia type
  • vision blurred
  • dysuria
5 - 10 years:
  • aphasia
  • breathlessness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • nausea
  • numbness and tingling
  • anxiety
  • gambling
  • high blood pressure
  • resting tremor
  • weight gain - unintentional
not specified:
  • drug ineffective
  • weight increased
  • pain
  • fatigue
  • nausea
  • weight decreased
  • fall
  • amnesia
  • somnolence
  • back pain

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • drug ineffective
  • weight increased
  • anxiety
  • back pain
  • fall
  • oedema peripheral
  • arthralgia
  • somnolence
male:
  • depression
  • fatigue
  • disorientation
  • amnesia
  • asthenia
  • neuropathy peripheral
  • cognitive disorder
  • myopathy
  • alanine aminotransferase increased
  • aspartate aminotransferase increased

Most common drug interactions by age *:

20-29:
  • deep vein thrombosis
  • pulmonary embolism
30-39:
  • dysuria
40-49:
  • fall
  • headache
  • nausea
  • oedema peripheral
  • muscle spasms
  • sinusitis
  • somnolence
  • amnesia
  • arthralgia
  • back pain
50-59:
  • nausea
  • constipation
  • drug ineffective
  • weight increased
  • anxiety
  • depression
  • disorientation
  • dyspepsia
  • insomnia
  • restless legs syndrome
60+:
  • cardiac failure congestive
  • nausea
  • weight decreased
  • pain
  • anxiety
  • constipation
  • chronic obstructive pulmonary disease
  • aggression
  • confusional state
  • dehydration

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meloxicam and Requip?

Can you answer these questions?

More questions for: Meloxicam, Requip

You may be interested in these reviews

More reviews for: Meloxicam, Requip

On eHealthMe, Meloxicam (meloxicam) is often used to treat arthritis. Requip (ropinirole hydrochloride) is often used to treat restless leg syndrome. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.